Mayo Score for UC Calculator

Mayo Score for UC Calculator for Gastroenterology. Common activity bands are: 0 to 2 (with no individual subscore above 1) remission, 3 to 5 mild, 6 to 10 moderate, and 11 to 12 severe. Two treatment targets built on this score are widely used as endpoints: clinical response, defined as a drop of at least 3 points and at least 30 percent from baseline with a rectal bleeding subscore of 0 or 1 (or a 1-point fall in it), and clinical remission, typically a total of 2 or less with no subscore above 1. The endoscopic subscore carries independent weight: an endoscopic subscore of 0 or 1 defines mucosal healing, and achieving 0 (versus 1) is linked to lower rates of relapse, hospitalization, and colectomy, which is why many now target an endoscopic subscore of 0.

How this calculator works

The Mayo Score sums four components, each rated 0 to 3, giving a total of 0 to 12: stool frequency relative to the patient's own normal, rectal bleeding, the physician's global assessment, and the endoscopic appearance of the mucosa (the endoscopic subscore). Two of the four items are subjective clinician impressions and one requires endoscopy, so a complete score depends on sigmoidoscopy or colonoscopy performed near the assessment. When endoscopy is unavailable, the Partial Mayo Score (the same three non-endoscopic items, range 0 to 9) is calculated instead and is the version used for routine clinic and telehealth follow-up.

When to use this calculator

Use it to grade disease activity in established ulcerative colitis, most often at baseline and on-treatment visits and as the primary or secondary endpoint in UC drug trials. It applies to adults with confirmed UC of any extent, since the endoscopic subscore is read from the most inflamed segment rather than requiring full colonoscopy. Do not use it to diagnose UC, to assess Crohn disease or indeterminate colitis, or to grade acute severe colitis in hospital, where the Truelove and Witts criteria and CRP/albumin drive escalation and colectomy decisions.

Inputs used

  • Stool frequency
  • Rectal bleeding
  • Endoscopic findings
  • Physician global assessment

Clinical interpretation

Common activity bands are: 0 to 2 (with no individual subscore above 1) remission, 3 to 5 mild, 6 to 10 moderate, and 11 to 12 severe. Two treatment targets built on this score are widely used as endpoints: clinical response, defined as a drop of at least 3 points and at least 30 percent from baseline with a rectal bleeding subscore of 0 or 1 (or a 1-point fall in it), and clinical remission, typically a total of 2 or less with no subscore above 1. The endoscopic subscore carries independent weight: an endoscopic subscore of 0 or 1 defines mucosal healing, and achieving 0 (versus 1) is linked to lower rates of relapse, hospitalization, and colectomy, which is why many now target an endoscopic subscore of 0.

Worked example

A patient reports two to three extra stools daily over baseline (subscore 2), visible blood with most stools (subscore 2), a physician global assessment of moderate disease (subscore 2), and sigmoidoscopy showing marked erythema, absent vascular pattern, and friability without ulceration (endoscopic subscore 2). Total Mayo Score = 8 of 12, placing the patient in the moderate range. If a biologic is started and repeat endoscopy weeks later shows only mild erythema (endoscopic subscore 1) with stool frequency and bleeding both dropping to 0, the total falls to roughly 1 to 2, meeting a clinical response (a fall of at least 3 points and 30 percent) and approaching remission.

Limitations and safety notes

The physician global assessment is subjective and overlaps conceptually with the other three items, inflating internal correlation and inter-rater variability; central reading of the endoscopic subscore reduces but does not eliminate this. The endoscopic subscore has poor reproducibility at the boundary between grades 1 and 2 (friability), the exact distinction that separates mucosal healing from active disease, so borderline reads can flip a remission call. The score does not incorporate histology, extent of colitis, or biomarkers, and the endoscopic component reflects only the single worst-appearing segment, potentially missing more proximal activity.

Frequently asked questions

What is the difference between the full and partial Mayo Score?

The full score (0 to 12) includes the endoscopic subscore and requires sigmoidoscopy or colonoscopy. The Partial Mayo Score (0 to 9) drops the endoscopy item and uses only stool frequency, rectal bleeding, and physician global assessment, making it practical for routine or remote visits between scopes.

What Mayo Score counts as remission?

Clinical remission is usually defined as a total Mayo Score of 2 or less with no individual subscore greater than 1. Note that a total of 2 alone is not enough; a single high subscore, for example active bleeding, excludes remission.

Why does an endoscopic subscore of 0 matter if 1 already counts as healed?

Both 0 and 1 meet the traditional definition of mucosal healing, but complete normalization (subscore 0) is associated with fewer relapses, hospitalizations, and colectomies than a subscore of 1. Many clinicians and trials now use an endoscopic subscore of 0 as a more stringent target.

Can the Mayo Score be used for acute severe UC in hospital?

No. It was designed for mild to moderate outpatient disease and lacks the systemic markers (heart rate, temperature, hemoglobin, ESR) that drive inpatient management. Use the Truelove and Witts criteria plus CRP and albumin for acute severe colitis and steroid-response decisions.

References

  • Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987. PMID: 3317057.
  • Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005. PMID: 16339095.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: June 21, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators